the aid library

LIST OPTIONS

Filter

8639

UNAIDS Terminology Guidelines

UNAIDS (2024) CC

Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind... more

Download (419)

View PDF (431)

HIV and AIDS

Rediscovering Biology (2019) C2

Rediscovering Biology Molecular to Global Perspectives Accessed: 03.09.2019

Download (750)

View PDF (1597)

Integrating palliative care and symptom relief into primary health care : WHO guide for planners, implementers and managers

World Health Organization WHO (2018) C_WHO

Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p... more

Download (177)

View PDF (165)

South Africa - Country Cooperation Strategy 2023 - 2027

World Health Organization WHO (2025) C_WHO

The South African WHO Country Cooperation Strategy (CCS) 2023–2027 focuses on four key strategic priorities based on the country’s health needs and disease epidemiology, while also considering the need for building resilient health systems for UHC and health security in the post pandemic period.... more

Download (466)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1239)

View PDF (2712)

HIV and Mobility: Compendium of Migration and HIV and Aids Interventions

Jose Michael International Organization for Migration (IOM) (2009) C_WHO

This publication by UNAIDS, UNDP and the International Organisation for Migration examines various dimensions related to migration and HIV and AIDS.

Download (463)

View PDF (617)

Time To Act Stopping Violence, Safeguarding Health Care

International Committee of the Red Cross (ICRC) (2017) C1

Doctors, nurses, ambulance drivers and first-aiders are coming under attack while trying to save lives. They are threatened, arrested or beaten, their hospitals looted or bombed. Some are unable to work because medical supplies can’t get through; some are forced to flee for their lives. Some are e... more

Download (290)

View PDF (284)

Biobehavioural Survey Guidelines

A. Abdul-Quader, M. Berry, T. Bingham; et al. UNAIDS; World Health Organization; fhi360; et al. (2017) C_WHO

Global HIV Strategic Information Working Group For Populations At Risk For HIV

Download (573)

View PDF (669)

Mobile Populations

M. Smelyanskaya, J. Duncan (The Focus Group Consulting); C. Daniels, et al. Stop TB Partnership; UNOPS; END TB (2015) C1

Key populations brief.

Download (1407)

View PDF (1832)

Satellite Imagery Interpretation Guide : Displaced Population Camps

Isaac L. Baker, Brittany L. Card, Nathaniel A. Raymond Harvard Humanitarian Initiative (2012)

Camps is intended to help address the absence of public and standardized training resources for those seeking to use high resolution satellite imagery in support of refugee/IDP assistance operations. Students, general audiences, and volunteers studying and analyzing satellite imagery of displaced po... more

Download (524)

View PDF (806)

Integrated School Health Policy

Department of Health & Department of Basic Education, Republic of South Africa (2012) C2

Download (291)

View PDF (325)

Biobehavioural Survey Guidelines - For Populations at risk for HIV

A. Abdul-Quader; M. Berry; T. Bingham; J. Burnett; et al. Centers for Diseases Control and Prevention; UNAIDS; World Health Organization; et al. (2017) C_WHO

Global HIV Strategic Information Working Group

Download (559)

View PDF (1115)

Integrating palliative care and symptom relief into responses to humanitarian emergencies and crises: a WHO guide

World Health Organization WHO (2018) C_WHO

Humanitarian emergencies and crises (Humanitarian emergencies and crises) are large-scale events that may result in the breakdown of health care systems and society, forced displacement, death, and physical, psychological, social and spiritual suffering on a massive scale. Current responses to Human... more

Download (259)

View PDF (267)

Fast-tracking HIV treatment: Parliamentary action and policy options

P. Bayr; L. Davies; F. Ndugulile; et al. Inter-Parliamentary Union (For democracy, For everyone); UNAIDS (2015) C2

Download (348)

View PDF (304)

Climate Change and Health - Training Modules

World Health Organization (WHO) - Regional Office for South-East Asia (2015) C_WHO

Training Modules for climate change and Health - WHO

Download (1947)

View PDF (4071)

How To Add Deworming To Vitamin A Distribution

World Health Organization, UNICEF (2004)

Download (985)

View PDF (2340)

Key messages for social mobilization and community engagement in intense transmission areas

World Health Organization (2014)

The messages should be used to inform, educate and engage different audience groups depending on their level of risk, vulnerability, presence in contact areas, care of patients with Ebola, or engagement or attendance of burials.

External Link

Rapid Risk Assessment of Acute Public Health Events
recommended

World Health Organization 2012 (2011) C_WHO

This manual has been developed to guide rapid risk assessment of acute public health risks from any type of hazard in response to requests from Member States of the World Health Organization (WHO). The manual is aimed primarily at national departments with health-protection responsibilities, Nationa... more

Download (352)

View PDF (413)

World Drug Report 2019 Booklet 5 Drugs and the environment

United Nations Office on Drug and Crime UNODC (2022) C2

The booklet starts with a general overview of how illicit drugs and the environment are linked within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability. It highlights direct and indirect linkages and gives examples of the significant local and i... more

Download (927)

View PDF (1807)

A global brief on vector-borne diseases

World Health Organization (2014) C_WHO

With this World Health Day, WHO is drawing attention to a group of diseases that are spread by insects and other vectors, the heavy health and economic burdens they impose, and what needs to be done to reduce these burdens. Many of these diseases have been historically confined to distinct geographi... more

Rapid Risk Assessment of Acute Public Health Events recommended

Rapid Risk Assessment of Acute Public Health Events
recommended